3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
13
Multiple Myeloma
6
Lymphoma
5
Lung Neoplasms
5
Melanoma
3
Hematologic Neoplasms
3
Uveal Melanoma
2
Stomach Neoplasms
2
Colorectal Neoplasms
2
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Triple Negative Breast Neoplasms
1
Thyroid Neoplasms
1
Rectal Neoplasms
1
Prostatic Neoplasms
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Neurofibromatosis 2
1
Neoplasms
1
Neoplasm Metastasis
1
Multiple Endocrine Neoplasia Type 2a
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Large-Cell, Anaplastic
1
Granuloma, Plasma Cell
1
Glioma
1
Esophageal Neoplasms
1
Endometrial Neoplasms
1
Endometrial Cancer Recurrent
1
Colonic Neoplasms
1
Interventions
Nivolumab
6
Ipilimumab
2
Gemcitabine
2
zaleplon
1
temsirolimus
1
relatlimab
1
regorafenib
1
olaparib
1
linrodostat
1
Vorinostat
1
Trastuzumab
1
Standard of Care
1
Sirolimus
1
Rehabilitation
1
Psychotherapy
1
Paclitaxel
1
Oxaliplatin
1
Niacin
1
IFL protocol
1
Health Services Needs and Demand
1
Everolimus
1
Clinical Trials, Phase IV as Topic
1
Cisplatin
1
Capecitabine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Advanced Cancer
×
Crizotinib
×
1 year
×
Clear all
No trials found.